Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Table of Contents

Proc Amer Assoc Cancer Res, Volume 45, 2004

  • Best Abstracts Plenary Session
  • Carcinogenesis 1: Hormonal Carcinogenesis
  • Carcinogenesis 2: Molecular Carcinogenesis
  • Carcinogenesis 3: Premalignant Lesions/Oxidative Stress
  • Carcinogenesis 4: DNA Damage and Repair
  • Carcinogenesis 5: Animal and In Vitro Models for Carcinogenesis I
  • Carcinogenesis 6: DNA Damage and Repair I
  • Carcinogenesis 7: Environmental Carcinogenesis and Tumor Progression
  • Carcinogenesis 8: Chemical Carcinogenesis
  • Carcinogenesis 9: Molecular and Viral Carcinogenesis
  • Carcinogenesis 10: Signal Transduction and Gene Expression
  • Carcinogenesis 11: Viral Carcinogenesis
  • Carcinogenesis 12: Mutagenesis
  • Carcinogenesis 13: Animal and In Vitro Models of Carcinogenesis II
  • Cellular, Molecular, and Tumor Biology 1: Angiogenesis Inhibitors I
  • Cellular, Molecular, and Tumor Biology 2: Angiogenesis Inhibitors II
  • Cellular, Molecular, and Tumor Biology 3: Cell Membrane and Cytoplasmic Signaling Pathways
  • Cellular, Molecular, and Tumor Biology 15: Cell and Animal Cancer Models
  • Cellular, Molecular, and Tumor Biology 16: Cell Cycle Control and Checkpoints
  • Cellular, Molecular, and Tumor Biology 17: Cell Cycle Targeted Therapeutic Agents
  • Cellular, Molecular, and Tumor Biology 18: Cytoplasmic Signaling
  • Cellular, Molecular, and Tumor Biology 19: DNA Methylation: Markers
  • Cellular, Molecular, and Tumor Biology 20: Genomic Instability
  • Cellular, Molecular, and Tumor Biology 21: Imaging/Tumor Markers
  • Cellular, Molecular, and Tumor Biology 22: Mechanisms of Transcriptional Regulation II
  • Cellular, Molecular, and Tumor Biology 23: Senescence, Telomeres, and Telomerase
  • Cellular, Molecular, and Tumor Biology 24: Transcriptional Control of Cell Survival
  • Cellular, Molecular, and Tumor Biology 25: Tumor Microenvironment
  • Cellular, Molecular, and Tumor Biology 26: Chromatin Structure and Transcriptional Regulation
  • Cellular, Molecular, and Tumor Biology 27: DNA Methylation Inhibition
  • Cellular, Molecular, and Tumor Biology 28: Functional Genomics
  • Cellular, Molecular, and Tumor Biology 29: Gene Expression Studies: Technology, Informatics, and Cancer Biology
  • Cellular, Molecular, and Tumor Biology 30: Genome-wide Analysis in Brain Tumors and Animal Models
  • Cellular, Molecular, and Tumor Biology 31: Genome-wide Screening for Cancer-related Genes I
  • Cellular, Molecular, and Tumor Biology 32: Genomics/Proteomics to Study Tumor Progression
  • Cellular, Molecular, and Tumor Biology 33: Inflammation and Metastasis
  • Cellular, Molecular, and Tumor Biology 34: Molecular Alterations in Genitourinary Tumors
  • Cellular, Molecular, and Tumor Biology 35: Proteases and Protease Inhibitors
  • Cellular, Molecular, and Tumor Biology 36: Therapies against Tumor Invasion and Metastasis
  • Cellular, Molecular, and Tumor Biology 37: Tobacco-related Malignancies: Tumors of the Head and Neck and Lung
  • Cellular, Molecular, and Tumor Biology 38: Cancer Genetics: Searching for New Genes and Molecular Markers
  • Cellular, Molecular, and Tumor Biology 39: DNA Repair and Genomic Instability
  • Cellular, Molecular, and Tumor Biology 40: Proteases and Tumor Invasion
  • Cellular, Molecular, and Tumor Biology 41: Angiogenesis II: Novel Agents, Mechanisms, and Targets
  • Cellular, Molecular, and Tumor Biology 42: Genetic Regulation of Metastasis
  • Cellular, Molecular, and Tumor Biology 43: Oncogenic Transcription Factors
  • Cellular, Molecular, and Tumor Biology 44: Senescence and Immortalization
  • Cellular, Molecular, and Tumor Biology 45: Signaling and Therapeutics
  • Cellular, Molecular, and Tumor Biology 46: Signaling and Tumor Invasion
  • Cellular, Molecular, and Tumor Biology 47: Analysis of p53-MDM2-ARF Pathways
  • Cellular, Molecular, and Tumor Biology 48: Angiogenesis I: Inhibitors of VEGF and VEGF-Receptors
  • Cellular, Molecular, and Tumor Biology 49: Cyclins and Cyclin-dependent Kinases
  • Cellular, Molecular, and Tumor Biology 50: DNA Damage and Repair II
  • Cellular, Molecular, and Tumor Biology 51: DNA Damage and Repair III
  • Cellular, Molecular, and Tumor Biology 52: Molecular Alterations in Prostate Cancer
  • Cellular, Molecular, and Tumor Biology 53: Molecular Markers I
  • Cellular, Molecular, and Tumor Biology 54: Pediatric Oncology
  • Cellular, Molecular, and Tumor Biology 55: Receptor Signaling
  • Cellular, Molecular, and Tumor Biology 56: Regulatory Mechanisms in Skin Tumorigenesis
  • Cellular, Molecular, and Tumor Biology 57: Stem Cell Biology
  • Cellular, Molecular, and Tumor Biology 58: Transcriptional Control of Cellular Activities
  • Cellular, Molecular, and Tumor Biology 58: Transcriptional Control of Cellular Activities
  • Cellular, Molecular, and Tumor Biology 59: Tumor Classification and Genome and Transcriptome Scanning
  • Cellular, Molecular, and Tumor Biology 59: Tumor Classification and Genome and Transcriptome Scanning
  • Cellular, Molecular, and Tumor Biology 60: Angiogenic Gene Expression in Malignancy
  • Cellular, Molecular, and Tumor Biology 61: Bioinformatics: Genomics, Transcriptomics, and Systems Biology of Cancer
  • Cellular, Molecular, and Tumor Biology 62: Biomarkers for Metastasis
  • Cellular, Molecular, and Tumor Biology 63: Biomarkers for Tumor Progression
  • Cellular, Molecular, and Tumor Biology 64: Bone Metastasis
  • Cellular, Molecular, and Tumor Biology 65: Cell Surface Death Pathways I
  • Cellular, Molecular, and Tumor Biology 66: Cell Surface Death Pathways II
  • Cellular, Molecular, and Tumor Biology 67: Gene Regulation and Tumor Invasion
  • Cellular, Molecular, and Tumor Biology 68: Genome-wide Screening for Cancer-related Genes II
  • Cellular, Molecular, and Tumor Biology 69: MAP Kinase Cascade Signaling
  • Cellular, Molecular, and Tumor Biology 70: Molecular Alterations in Mammary Tumorigenesis
  • Cellular, Molecular, and Tumor Biology 71: PI3K/ AKT Signaling
  • Cellular, Molecular, and Tumor Biology 72: Proteomic Pattern Analysis for Cancer Diagnosis and Treatment
  • Cellular, Molecular, and Tumor Biology 73: Regulation of TRAIL-induced Apoptosis
  • Cellular, Molecular, and Tumor Biology 74: Regulators of Increased Angiogenesis
  • Cellular, Molecular, and Tumor Biology 75: siRNA and Gene Silencing
  • Cellular, Molecular, and Tumor Biology 76: Therapeutic and Diagnostic Marker Discovery Using Proteomics
  • Cellular, Molecular, and Tumor Biology 77: Cytoplasmic and Nuclear Signaling
  • Cellular, Molecular, and Tumor Biology 78: Host and Tumor Genomic Instability
  • Cellular, Molecular, and Tumor Biology 79: Ubiquitin Ligases and Associated Kinases at Key Cell Cycle Checkpoints
  • Cellular, Molecular, and Tumor Biology 80: Angiogenesis Inhibitors III
  • Cellular, Molecular, and Tumor Biology 81: Apoptosis-inducing Agents
  • Cellular, Molecular, and Tumor Biology 82: Cell and Tissue Radiation Biology
  • Cellular, Molecular, and Tumor Biology 83: DNA Methylation and Chromatin
  • Cellular, Molecular, and Tumor Biology 84: DNA Methylation: New Genes
  • Cellular, Molecular, and Tumor Biology 84: DNA Methylation: New Genes
  • Cellular, Molecular, and Tumor Biology 85: Functional Analyses of Nuclear Oncogenes and Tumor Suppressors
  • Cellular, Molecular, and Tumor Biology 86: Gene Expression
  • Cellular, Molecular, and Tumor Biology 87: Genetic and Epigenetic Changes in Cancer
  • Cellular, Molecular, and Tumor Biology 88: Molecular Markers II
  • Cellular, Molecular, and Tumor Biology 89: Mouse Models of Prostate and Gastrointestinal Cancers
  • Cellular, Molecular, and Tumor Biology 89: Mouse Models of Prostate and Gastrointestinal Cancers
  • Cellular, Molecular, and Tumor Biology 90: Non-ionizing Radiation
  • Cellular, Molecular, and Tumor Biology 91: Receptor Tyrosine Kinase Signaling
  • Cellular, Molecular, and Tumor Biology 92: Regulation of Apoptosis I
  • Cellular, Molecular, and Tumor Biology 93: Signaling and Therapeutics II
  • Cellular, Molecular, and Tumor Biology 94: Advances in Proteomics Applied to Cancer Detection and Treatment
  • Cellular, Molecular, and Tumor Biology 95: Angiogenesis Mechanisms and Microenvironment
  • Cellular, Molecular, and Tumor Biology 95: Angiogenesis Mechanisms and Microenvironment
  • Cellular, Molecular, and Tumor Biology 96:: Bioinformatics and Cancer: Tools, Resources, and Biology
  • Cellular, Molecular, and Tumor Biology 97: Cell Surface Receptor Signaling
  • Cellular, Molecular, and Tumor Biology 98: Mechanisms of Apoptosis
  • Cellular, Molecular, and Tumor Biology 99: DNA Methylation Profiles
  • Cellular, Molecular, and Tumor Biology 100: Activation of Apoptosis by Novel Therapeutic Agents
  • Cellular, Molecular, and Tumor Biology 101: Adhesion and Signaling in Cancer Progression
  • Cellular, Molecular, and Tumor Biology 102: Angiogenesis III
  • Cellular, Molecular, and Tumor Biology 103: Apoptosis Detection and Regulation
  • Cellular, Molecular, and Tumor Biology 104: Kinase-mediated Cell Survival and Apoptosis
  • Cellular, Molecular, and Tumor Biology 105: Matrix and Adhesion in Cancer Metastasis I
  • Cellular, Molecular, and Tumor Biology 106: Matrix and Adhesion in Cancer Metastasis II
  • Cellular, Molecular, and Tumor Biology 107: Molecular Alterations in Gastrointestinal Tumor Formation
  • Cellular, Molecular, and Tumor Biology 108: Mouse Models of Human Cancer
  • Cellular, Molecular, and Tumor Biology 109: Preclinical Science and Imaging in Cancer Models
  • Cellular, Molecular, and Tumor Biology 110: Protein Kinase C Signaling
  • Cellular, Molecular, and Tumor Biology 111: Regulation of Apoptosis II
  • Cellular, Molecular, and Tumor Biology 112: Signaling and Therapeutics III
  • Cellular, Molecular, and Tumor Biology 113: Cytoplasmic Signaling by Oncogenes and Tumor Suppressors
  • Cellular, Molecular, and Tumor Biology 114: Molecular and Cellular Determinants of Radiation Response
  • Cellular, Molecular, and Tumor Biology 115: Nuclear Oncogenes and Tumor Suppressors
  • Cellular, Molecular, and Tumor Biology 116: Single and Multiple Gene Alterations in Murine Cancer Models
  • Cellular, Molecular, and Tumor Biology 117: Therapeutic Applications Based on Apoptotic Pathways
  • Chemistry 1: Chemical Topics in Drug Therapy, Radiation Therapy, Imaging, and Structure Biology
  • Chemistry 2: Chemical Aspects of Carcinogenesis
  • Chemistry 3: DNA as a Target for Drugs and Carcinogens
  • Chemistry 4: SAR and Structural Biology Studies of Drug Candidates
  • Chemistry 5: Proteomics and Chemistry
  • Clinical Research 1: Drug Resistance, Pharmacogenomics, and Pharmacokinetics
  • Clinical Research 2: Molecular Diagnosis and Prognosis I
  • Clinical Research 3: Molecular Classification of Tumors
  • Clinical Research 4: Molecular Diagnosis and Prognosis II
  • Clinical Research 5: Emerging Concepts and Targets in Immunotherapy
  • Clinical Research 6: Novel Prognostic and Predictive Factors
  • Clinical Research 7: Molecular Markers of Metastasis and Progression
  • Clinical Research 8: Laboratory Correlates/New Targeted Agents/Methodology for New Study Design
  • Clinical Research 9: Molecular Detection of Metastasis and Genetic Alteration in Cancer
  • Clinical Research 10: Early Detection: Strategies and Technologies
  • Clinical Research 10:: Early Detection: Strategies and Technologies
  • Clinical Research 11: Clinical Investigations II: Gastrointestinal Cancers/Head and Neck Cancers/Hormone-related Cancers/ Leukemia and Lymphoma
  • Clinical Research 12: Clinical Investigations III: Lung Cancer/Ovarian and Other Gynecologic Cancers
  • Clinical Research 13: Clinical Investigations IV: Prostate and Other Genitourinary Cancers
  • Clinical Research 14: Clinical Pharmacology/Pharmacogenomics
  • Clinical Research 15: Clinical Investigations V: Brain and Other CNS Tumors/Breast Cancer/Melanoma
  • Clinical Research 16: Molecular and Morphologic Tumor Staging/Imaging
  • Clinical Research 17: Global Molecular Classification and Diagnosis
  • Educational Session: Advances in High-Throughput Genotyping
  • Educational Session: Biologic Agents as Radiation Response Modifiers
  • Educational Session: Chemical Biology in Anticancer Drug Discovery
  • Educational Session: Chromatin Structure and Function in Cancer
  • Educational Session: Hypoxia: Impact on Cancer Biology
  • Educational Session: Molecular Imaging Strategies
  • Educational Session: RNA Interference: A Tool for Gene Silencing
  • Educational Session: Registration Strategies in Cancer Drug Development: Opportunities and Challenges
  • Educational Session: Research Paradigms in Anticancer Drug Discovery and Development
  • Educational Session: Stem Cells and Cancer
  • Educational Session: Structural Biology and Its Practical Aspects in Drug Discovery
  • Educational Session: Studying Genetic Modifiers in Experimental and Human Cancer
  • Educational Session: Targeting Signal Transduction Pathways
  • Educational Session: Zebrafish as an Animal Model in Cancer Research
  • Endocrinology 1: Endocrinology I
  • Endocrinology 2: Endocrinology II
  • Endocrinology 3: Endocrinology III
  • Endocrinology 4: Endocrinology IV
  • Endocrinology 5: Endocrinology V
  • Epidemiology 1: Viral, Bacterial, and Dietary Exposures
  • Epidemiology 2: Epidemiology of Breast and Prostate Cancer
  • Epidemiology 3: Immune Response and Exposure Modifying Genes in Diverse Neoplasms
  • Epidemiology 4: DNA Repair Genotype/Phenotype II
  • Epidemiology 5: Biomarkers of Human Exposure to Carcinogens
  • Epidemiology 6: Endogenous and Exogenous Factors in Breast and Prostate Cancer
  • Epidemiology 7: DNA Repair Genotype/Phenotype I
  • Epidemiology 8: Methods, Genotype/Phenotype and Carcinogen Metabolism Genes
  • Epidemiology 9: Risk Factors and Modeling
  • Epidemiology 10: Smoking and Cancer: Lung, Head and Neck, and Bladder Cancer
  • Epidemiology 11: Genetic Epidemiology of Breast, Prostate, and Gynecologic Cancers: Hormone and Carcinogen Metabolism
  • Epidemiology 12: Polymorphisms in Diverse Genes Associated with Gastrointestinal Lesions
  • Epidemiology 13: Genetic Susceptibility to Squamous and Transitional Cell Cancers
  • Experimental and Molecular Therapeutics 1: ABC Transporters in Drug Resistance
  • Experimental and Molecular Therapeutics 2: Drug Accumulation and Metabolism as Mechanisms of Drug Resistance
  • Experimental and Molecular Therapeutics 3: Investigational Combinations/Modulators I
  • Experimental and Molecular Therapeutics 4: Mechanisms of Action
  • Experimental and Molecular Therapeutics 5: Molecular Profiling of Drug Resistance
  • Experimental and Molecular Therapeutics 6: Novel Delivery Strategies
  • Experimental and Molecular Therapeutics 7: Cellular Responses to Alkylating Agents
  • Experimental and Molecular Therapeutics 8: Diagnostic Markers, Imaging, and Microarrays
  • Experimental and Molecular Therapeutics 9: Gene Therapy I
  • Experimental and Molecular Therapeutics 10: Novel Mechanisms of Drug Resistance
  • Experimental and Molecular Therapeutics 11: Specific Immune Mechanisms and Cancer Vaccines: Clinical Studies
  • Experimental and Molecular Therapeutics 12: New Targets, Agents, and Delivery Strategies
  • Experimental and Molecular Therapeutics 13: Novel Therapeutic Agents I
  • Experimental and Molecular Therapeutics 14: Investigational Combinations/Modulators II
  • Experimental and Molecular Therapeutics 15: Molecular Pharmacology, Pharmacokinetics and Pharmacogenomics
  • Experimental and Molecular Therapeutics 16: Novel Agents: Targets and Mechanisms
  • Experimental and Molecular Therapeutics 17: Novel Screens/Targets and Dosing Approaches
  • Experimental and Molecular Therapeutics 18: Pharmacogenomics, Preclinical Toxicology, Pharmacokinetics
  • Experimental and Molecular Therapeutics 19: Reversing or Overcoming Drug Resistance
  • Experimental and Molecular Therapeutics 20: Gene Expression Profiling of Drug Action
  • Experimental and Molecular Therapeutics 21: Cell Cycle Checkpoint and Kinase Inhibition
  • Experimental and Molecular Therapeutics 22: Novel Strategies for Gene Delivery
  • Experimental and Molecular Therapeutics 23: Histone Deacetylase Inhibitors
  • Experimental and Molecular Therapeutics 24: Novel Mechanisms of Drug Resistance and Functional Characterization
  • Experimental and Molecular Therapeutics 25: Apoptotic Pathways and the Immune System
  • Experimental and Molecular Therapeutics 26: Molecular Targets of Antimetabolites
  • Experimental and Molecular Therapeutics 27: Natural Products
  • Experimental and Molecular Therapeutics 28: Novel Targets and Approaches for Angiogenesis and Signaling Pathways
  • Experimental and Molecular Therapeutics 29: Novel Therapeutic Agents II
  • Experimental and Molecular Therapeutics 30: Target Identification
  • Experimental and Molecular Therapeutics 31: Topoisomerase, Telomerase, and Nucleosides/Nucleotides
  • Experimental and Molecular Therapeutics 32: Cellular Pharmacology and Pharmacogenomics
  • Experimental and Molecular Therapeutics 33: Gene Therapy II
  • Experimental and Molecular Therapeutics 34: Genes, Drugs, and Novel Agents
  • Experimental and Molecular Therapeutics 35: Preclinical Models/Pharmacology/Mechanisms
  • Experimental and Molecular Therapeutics 36: Signal Transduction Inhibitors
  • Experimental and Molecular Therapeutics 37: Signaling Targets
  • Experimental and Molecular Therapeutics 38: Novel Therapeutic Agents III: Signaling Inhibitors
  • Experimental and Molecular Therapeutics 39: Novel Therapeutic Agents IV: Small Molecule Inhibitors
  • Experimental and Molecular Therapeutics 40: Proteosome Inhibition and Histone Deacetylase Inhibitors
  • Experimental and Molecular Therapeutics 41: Antiangiogenesis
  • Experimental and Molecular Therapeutics 41: Antiangiogenesis
  • Experimental and Molecular Therapeutics 42: Cell and Stroma-directed New Agents
  • Experimental and Molecular Therapeutics 43: Gene Therapy III
  • Experimental and Molecular Therapeutics 44: Platinum Compounds/Antimetabolites/Taxanes
  • Experimental and Molecular Therapeutics 45: Small Molecules: Signaling and Apoptosis Targets
  • Experimental and Molecular Therapeutics 46: Cell Signaling Inhibitors
  • Experimental and Molecular Therapeutics 47: Cellular Responses to Anticancer Drugs
  • Experimental and Molecular Therapeutics 48: Growth Factor Receptors as Therapeutic Targets
  • Experimental and Molecular Therapeutics 49: Molecular Targeted Agents
  • Experimental and Molecular Therapeutics 50: New Approaches to Classic Targets
  • Experimental and Molecular Therapeutics 51: Pharmacokinetics and Pharmacodynamics
  • Experimental and Molecular Therapeutics 52: Tubulin-targeted Agents
  • Experimental and Molecular Therapeutics 53: Microtubule Inhibitors
  • Experimental and Molecular Therapeutics 54: Small Molecules: Cell Cycle and Signaling Inhibitors
  • Immunology/Tumor Immunobiology 1: Lymphokines, Cytokines, and Growth Factors in Tumor Immunity I
  • Immunology/Tumor Immunobiology 2: Tumors and the Immune System: Immunotherapy and Immunomodulation I
  • Immunology/Tumor Immunobiology 3: Specific Immunomechanisms and Cancer Vaccines: Basic Studies I
  • Immunology/Tumor Immunobiology 4: Specific Immunomechanisms and Cancer Vaccines: Basic Studies II
  • Immunology/Tumor Immunobiology 5: Tumors and the Immune System: Immunotherapy and Immunomodulation II
  • Immunology/Tumor Immunobiology 6: Molecular and Cellular Mechanisms of Antitumor Immunity
  • Immunology/Tumor Immunobiology 7: Innovative Approaches to Immunotherapy of Tumors
  • Immunology/Tumor Immunobiology 8: Lymphokines, Cytokines, and Growth Factors in Tumor Immunity II
  • Immunology/Tumor Immunobiology 9: Specific Immunomechanisms and Cancer Vaccines: Basic Studies III
  • Immunology/Tumor Immunobiology 10: Cancer Vaccines: Preclinical Studies
  • Immunology/Tumor Immunobiology 11: Tumor Antigens and Animal Models for Immunotherapy I
  • Immunology/Tumor Immunobiology 12: Tumor Antigens and Animal Models for Immunotherapy II
  • Integrated Session 1: Growth Factors and Antibodies in Tumor Immunotherapy
  • Integrated Session 2: Cell Signaling and Apoptosis after Radiation
  • Integrated Session 3: Clinical Cancer Genetics
  • Integrated Session 4: Clinical Prevention Studies
  • Integrated Session 5: Modification of Radiation Sensitivity
  • Integrated Session 6: Immunotherapy and Combined Modality Approaches
  • Integrated Session 7: Pediatric Oncology
  • Integrated Session 8: Radiation: Normal Tissue Damage, Protectors, and Predictive Assays
  • Integrated Session 9: Racial and Ethnic Minorities and the Medically Underserved: Multidisciplinary Research into Biology, Outcomes, and Disparities
  • Integrated Session 10: Human Prevention/Screening Studies
  • Integrated Session 11: Proteomics
  • Opening Plenary Session: Targeting the Conquest of Cancer through Conceptual Integration and Innovation
  • Prevention Research 1: Chemoprevention Studies I
  • Prevention Research 2: Biological and Biochemical Mechanisms in Prevention
  • Prevention Research 3: Molecular Targets for Cancer Prevention: Development of New Agents
  • Prevention Research 5: Chemoprevention Studies II
  • Prevention Research 6: Molecular Markers in Prevention Research
  • Prevention Research 7: Diet and Cancer
  • Prevention Research 8: Mechanistic Pathways Modulated by Natural Products
  • Prevention Research 9: New Agents and Mechanisms in Chemoprevention of Prostate and Breast Cancer
  • Prevention Research 10: Biomarkers and Intervention Studies
  • Supportive Care and Survivorship Research 1: Psychosocial Research in Cancer
  • Symposium: Cellular and Molecular Determinants of Metastasis
  • Symposium: Challenges for Integrating Targeted Therapies
  • Symposium: DNA Damage Signaling
  • Symposium: Genetic Model Systems to Dissect Cancer
  • Symposium: Genetic Modifiers of Cancer Risk
  • Symposium: Genomic and Chromosomal Instability
  • Symposium: Nuclear Receptors and Cancer Prevention
  • Symposium: Obesity, Metabolism and Cancer
  • Symposium: Outside-In Signaling in Cancer
  • Symposium: Pharmacogenomics and Response Prediction
  • Symposium: Role of DNA Repair Genotype and Phenotype in Cancer Susceptibility
  • Symposium: Systems Biology of Cancer: The Tumor as an Organ
  • Symposium: The Ubiquitin-Proteasome System and Cancer
Back to top
PreviousNext
April 2004
Volume 64, Issue 7 Supplement
  • Table of Contents

Sign up for alerts

Advertisement
  • Most Cited
  • Most Read
Loading
  • Towards Multidrug Adaptive Therapy
  • MEK Inhibition Synergizes with Statins for Cancer Treatment
  • IL1β Promotes Immune Suppression in Pancreatic Cancer
  • Multiple Primary Cancer Penetrance for TP53
  • Metabolomic Gradients in Glioblastoma Models
More...
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement